[Federal Register Volume 64, Number 52 (Thursday, March 18, 1999)]
[Notices]
[Page 13413]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-6606]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Government-Owned Inventions Available for Licensing

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of the general 
availability of exclusive or partially exclusive licenses under the 
following pending patents. Any license granted shall comply with 35 USC 
209 and 37 CFR Part 404. Applications will be evaluated utilizing the 
following criteria: (1) Ability to manufacture and market the 
technology; (2) manufacturing and marketing capability; (3) time 
required to bring technology to market and production rate; (4) 
royalties; (5) technical capabilities; (6) Small business status.

    Serial No. 60/101001 entitled ``Intestinal Hydrogen Removal 
Using Hydrogen-metabolizing Microbes,'' dated September 18, 1998; 
Serial No. 08/595688 entitled ``Rapid Immunoassay for 
Periodontopathic Bacteria,'' dated February 2, 1996; Serial No. 09/
044214 entitled ``Rapid Immunoassay to Detect Infection With 
Mycobacterium tuberculosis,'' dated November 27, 1995; Serial No. 
08/766203 entitled ``Rapid Immunoassay for Cariogenic Bacteria,'' 
dated December 12, 1996; Serial No. 07/583170 entitled ``Rapid 
Microbial Protease Assay,'' dated January 4, 1996; Serial No. 08/
556391 entitled ``Method and System for Removing Mercury From Dental 
Waste Water,'' dated December 1, 1995; Serial No. 08/048042 entitled 
``Transgenic Mouse Expressing T Lymphocyte Activating Molecule, B7, 
on Pancreatic Beta Cells,'' dated February 17, 1994; Serial No. 
82,004 entitled ``Composition and Method to Prevent Graft Rejection 
and Other Counter Adaptive T Lymphocyte Mediated Immune Responses,'' 
dated June 11, 1997; Serial No. 60/077104 entitled ``PKC-mediated 
Dendritic Cell Differentiation Pathway,'' dated March 6, 1998; 
Serial No. 60/049389 entitled ``Blocking the Rejection of an 
Allograft Using the Combination of CD28 Pathway Blocker (CTLAY-Ig) 
and Anti-CD40L, in Primates,'' dated June 11, 1997; Serial No. 08/
587609 entitled ``Murine Hybridoma and Antibody Binding to CD28 
Receptor Secreted by the Hybridoma and Method of Using the 
Antibody,'' dated January 17, 1996; Serial No. 82011 entitled 
``Human Brain Vascular Endothelial Cell Growth Medium and Method for 
Expansion of Primitive CD34+,CD38-Bone Marrow Stem Cells,'' dated 
December 4, 1998; Serial No. 08/772,225 entitled ``Use of Oral 
Interleukin-6 as Therapy for Hemorrhagic Shock,'' dated December 20, 
1996; Serial No. 08/671,056 entitled ``Recombinant Fusion Protein 
Subunit Vaccine Against Dengue Virus Infection,'' dated June 27, 
1996; Serial No. 08/053450 Method of Use of Protective Malaria 
Sporozoite Surface Protein Immunogen and Gene,'' dated September 19, 
1997; Serial No. 08/176024 entitled ``Murine Monoclonal Antibodies 
Protective Against P. vivax Malaria,'' dated September 20, 1996; 
Serial No. 08/234027 entitled ``Method of Using Interleukin-12 to 
Provide Protection Against Infection with Malaria,'' dated August 
20, 1996; Serial No. 08/000906 entitled ``Pharmaceutical Composition 
of Esherichia coli Heat-labile Enterotoxin Adjuvant and Methods of 
Use,'' dated January 6, 1993; Serial No. 09/159568 entitled ``A 
Method to Preserve Bacteria in a Fully Dehydrated State Without 
Special Equipment,'' dated September 24, 1998; Serial No. 08/027254 
entitled ``Naked DNA Vaccine Against Hepatitis E Virus Infection,'' 
dated March 18, 1998; Serial No. 78,997 entitled ``CPG 
Immunostimulatory Motifs For the Prophylaxis of an Treatment for 
Malaria (P. falciparum, P. vivax, P. ovale and P. malarie),'' dated 
December 15, 1998; Serial No. 79,092 entitled ``Molecular Analysis 
of Attenuated Strains of Dengue Virus After Serial Passage in 
Primary Dog Kidney Cells,'' dated August 21, 1998; Serial No. 60/
101002 entitled ``The Increase in Seroreactivity of Surface Protein 
Antigen of typhus Rickettsia Due to Methylation,'' dated September 
18, 1998; Serial No. 08/869423 entitled ``PD2ME and p1012D2ME, 
Dengue-2 Virus DNA Vaccine,'' dated June 4, 1997; Serial No. 60/
108114 entitled ``Use of Recombinant Flagellin as Campylobacter 
Vaccine,'' dated July 15, 1997; Serial No. 60/068732 entitled 
``Expression and Refolding of the Major Outer Membrane Protein of 
Orientia tsutsugamushi and Its Use in Enzyme-linked Immunosorbant 
Assays,'' dated December 24, 1997; Serial No. 09/163,339 entitled 
``Diagnostic Monoclonal Antibody for Vibrio cholerae 0139,'' dated 
September 29, 1997; Serial No. 60/060,558 entitled ``Diagnostic 
Monoclonal Antibody for Vibrio cholerae 01,'' dated September 17, 
1996; Serial No. 60/082,947 entitled ``Method and Process for 
Establishment of Stage Specific Expression and Characterization of 
Proteins Based on Microbial or Human Genomic Sequence Data,'' dated 
April 24, 1998; Serial No. 60/107131 entitled ``Chromosome 2 
Sequence of the Human Malaria Parasite Plasmodium falciparum and 
Proteins of said Chromosome Useful in Anti-Malarial Vaccines and 
Diagnostic Reagents,'' dated October 30, 1998; Serial No. 08/155888 
entitled ``Polynucleotide Vaccine Protective Against Malaria, 
Methods of Protection and Vector for Delivering Polynucleotide 
Vaccines,'' dated November 23, 1993; Serial No. 8/917543 entitled 
``Rapid Detection and Quantification of Pathogens Using Filter 
Monitor Technology and Colony Lift Immunoassay,'' dated August 26, 
1997; Serial No. 60/069761 entitled ``Prevention or Reversal of 
Sensorineural Hearing Loss (SNHL) Through Biologic Mechanisms,'' 
dated July 31, 1998; and Serial No. 08/660000 Ultra-Low Temperature 
Neck Bonding Process,'' dated May 27, 1997.

DATES: Applications for an exclusive or partially exclusive license may 
be submitted at any time from the date of this notice.

ADDRESSES: Naval Medical Research Center, 8901 Wisconsin Ave, Bethesda, 
MD 20889-5607.

FOR FURTHER INFORMATION CONTACT: CDR Charles J. Schlagel, Marketing 
Director, Naval Medical Research Center, 8901 Wisconsin Ave, Bethesda, 
MD 20889-5607. Telephone (301) 295-5658.
Pamela A. Holden,
Lieutenant Commander, Judge Advocate General Corps, U.S. Navy, Federal 
Register Liaison Officer.
[FR Doc. 99-6606 Filed 3-17-99;8:45am]
BILLIING CODE 3810-FF-P